STEVEN ANZALDUA: Open Payments
NPI 1629815477 · ALICE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,199 in 43 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $519 · 2025 $1,199
Food & beverage: $1,199
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $418 |
| Lilly USA, LLC | 7 | $244 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| SHIELD THERAPEUTICS INC | 5 | $80 |
| Dexcom, Inc. | 4 | $80 |
| Radius Health, Inc. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $37 |
| Lundbeck LLC | 1 | $30 |
| Boston Scientific Corporation | 1 | $28 |
Products named: Ozempic, Wegovy, REXULTI, ZEPBOUND, MOUNJARO, ACCRUFER, Dexcom G6 Transmitter, Tymlos.
Industry payments across TX — which companies pay providers there.
